Higher Vedolizumab Trough Levels Associated with Remission in Inflammatory Bowel Disease (IBD) Patients During Maintenance Therapy

被引：0
|
作者：
Ungaro, Ryan [1 ]
Jossen, Jacqueline [1 ]
Phan, Becky [2 ]
Chefitz, Ezra
Jain, Anjali [1 ,3 ]
Naik, Snehal [3 ]
Dubinsky, Marla [4 ]
机构：
[1] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
[2] Icahn Sch Med Mt Sinai, Div Pediat Gastroenterol & Hepatol, New York, NY 10029 USA
[3] Prometheus Labs Inc, San Diego, CA USA
[4] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
来源：
INFLAMMATORY BOWEL DISEASES | 2017年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
PD-006
引用
收藏
页码：S7 / S7
页数：1
相关论文
共 50 条
  • [31] ASSOCIATION OF VEDOLIZUMAB LEVELS WITH CLINICAL AND BIOCHEMICAL MARKERS OF INFLAMMATION DURING MAINTENANCE THERAPY IN INFLAMMATORY BOWEL DISEASE
    Plevris, Nikolas
    Jones, Gareth-Rhys
    Jenkinson, Philip
    Lyons, Mathew
    Merchant, Lynne M.
    Pattenden, Rebecca J.
    Arnott, Ian
    Lees, Charlie W.
    GASTROENTEROLOGY, 2019, 156 (06) : S1142 - S1142
  • [32] Association of vedolizumab levels with clinical and biochemical markers of inflammation during maintenance therapy in inflammatory bowel disease
    Plevris, N.
    Jones, G. R.
    Jenkinson, P. W.
    Chuah, C. S.
    Lyons, M.
    Merchant, L. M.
    Pattenden, R. J.
    Arnott, I. D.
    Lees, C. W.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S347 - S347
  • [33] Vedolizumab Trough Levels in Inflammatory Bowel Disease: Initial Clinical Experience
    Badr, Al-Bawardy
    Guilherme, Piovezani Ramos
    Loftus, Edward, Jr.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S26 - S26
  • [34] Clinical utility of vedolizumab trough levels in the management of inflammatory bowel disease
    Maillard, Michel H.
    Jelk, Daniele
    Perreau, Matthieu
    Rossel, Jean-Benoit
    Pittet, Valerie
    Michetti, Pierre
    SWISS MEDICAL WEEKLY, 2018, 148 : 6S - 6S
  • [35] Vedolizumab trough levels predict clinical outcomes in inflammatory bowel disease
    Guidi, L.
    Pugliese, D.
    Tonucci, T. Panici
    Tolusso, B.
    Felice, C.
    Di Mario, C.
    Papa, A.
    Gremese, E.
    Gasbarrini, A.
    Rapaccini, G. L.
    Armuzzi, A.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S398 - S398
  • [36] Predictive value of infliximab trough levels in maintenance therapy for 5-year sustained clinical remission in patients with inflammatory bowel disease
    Jalali, Yashar
    Gojdicova, Anna
    Sturdik, Igor
    Toth, Jozef
    Koller, Tomas
    Huorka, Martin
    Jalali, Monika
    Payer, Juraj
    Hlavaty, Tibor
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2023, 124 (07): : 485 - 492
  • [37] Association between infliximab trough levels, clinical remission, mucosal healing and quality of life in patients with inflammatory bowel disease on maintenance therapy
    Parra, R. S.
    Feitosa, M. R.
    Feres, O.
    Rocha, J. J. R. D.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S292 - S292
  • [38] Therapeutic thresholds for infliximab trough levels during maintenance treatment in patients with inflammatory bowel disease
    Rasmussen, M.
    Brynskov, J.
    Ainsworth, M. A.
    Buhl, S.
    Bendtzen, K.
    Steenholdt, C.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S409 - S409
  • [39] CLINICAL USE OF INFLIXIMAB TROUGH LEVELS DURING MAINTENANCE IN PEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    van Hoeve, Karen
    Hoffman, Ilse
    Dreesen, Erwin
    Ferrante, Marc
    Ann, Gils
    Vermeire, Severine
    GASTROENTEROLOGY, 2018, 154 (06) : S1042 - S1042
  • [40] Higher Infliximab Trough Levels Are Associated With Better Outcome in Paediatric Patients With Inflammatory Bowel Disease
    van Hoeve, Karen
    Dreesen, Erwin
    Hoffman, Ilse
    Van Assche, Gert
    Ferrante, Marc
    Gils, Ann
    Vermeire, Severine
    JOURNAL OF CROHNS & COLITIS, 2018, 12 (11): : 1316 - 1325
12345